SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995, that focuses on seed to growth investments in deep technology across health, environmental tech, hardware, robotics, and cross border software, with a particular emphasis on Asia. The company runs accelerator style startup development programs, including HAX and IndieBio, which provide facilities, engineering resources, and lab equipment to help founders accelerate product development, acquire customers, and attract later stage funding. SOSV pursues a limited number of high potential startups, offering extensive hands on support to speed commercialization and scale, and aims to back innovations that improve human and planetary health.

OrbiMed is a healthcare-focused investment firm based in New York, founded in 1989, with approximately $5 billion in assets under management. It engages in private equity, venture capital, and growth investments across the global healthcare landscape, spanning biopharmaceuticals, biotechnology, life sciences tools, medical devices, diagnostics, health care services, and digital health. The firm invests across the development spectrum, from startup ventures to mature companies, and pursues opportunities worldwide, including North America, Europe, Asia, Israel and India, leveraging a long-standing specialization in the sector. Through its diversified capital programs, OrbiMed partners with management to advance innovative therapies, tools, and services that address significant medical needs.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

RA Capital Management is a Boston-based investment firm that specializes in life sciences and healthcare companies. The firm provides investment management and venture capital services, backing companies developing drugs, medical devices, diagnostics, and biotech tools. Its team combines expertise in biology, chemistry, and medicine with industry and business development experience. RA Capital supports companies across multiple stages, from seed funding to growth financings, including private and public rounds, and often takes board seats and seeks co-investment opportunities. Through its activity, it aims to identify technologies with potential to advance prevention and treatment, genetic testing and personalized medicine, and other patient-focused innovations.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages USD and RMB funds totaling about 9.5 billion in capital and backs early- and growth-stage technology, consumer, and healthcare companies. The firm has backed more than 530 portfolio companies, with over 200 exits via IPOs or M&A, and more than 70 unicorn or super unicorn companies.

Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines across neuroscience, cardiometabolic diseases, cancer, and immunology. It operates manufacturing and research facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in roughly 135 countries. The portfolio includes Verzenio, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, Humulin, Taltz, and Olumiant, reflecting a diversified, science‑driven approach. In addition to human medicines, Lilly conducts research in animal health to treat animal diseases and support agricultural productivity. The company maintains a strong emphasis on research and development to address unmet medical needs and to bring innovative therapies to patients worldwide.

Novo Nordisk is a global healthcare company that develops, manufactures, and distributes insulin and other diabetes medicines to treat chronic diseases. It pursues scientific breakthroughs and aims to expand access to its medicines, with the ultimate goal of preventing and curing disease.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, established in 2013. It targets individual accredited investors who previously had limited access to venture capital by enabling alumni from top entrepreneurial schools to invest together in ventures led by fellow alumni. The firm backs companies with an alumni connection and an institutional lead investor with sector expertise. It offers focused funds that provide accredited investors access to a diversified venture portfolio by type, sector, stage, and geography. The organization engages in seed, early-stage, and late-stage pre-IPO investments across technology, consumer, financial services, health care, life sciences, and other sectors.

New Enterprise Associates is a U.S.-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across stages and geographies, supporting startups from seed to growth. The firm operates globally with investments in the United States, Asia, and Brazil among others, and has a long track record of portfolio IPOs and acquisitions. It has over $19 billion in cumulative committed capital.

General Catalyst is a venture capital firm founded in 2000 that provides early-stage and growth equity investments in technology companies. It supports portfolio companies with momentum and mentorship to accelerate growth toward long-term success and typically engages across seed to growth stages, potentially taking minority or majority stakes. The firm targets a broad range of sectors enabled by software and technology, including consumer, enterprise, fintech, crypto, healthcare IT, and related areas, and maintains a multi-region presence with offices in North America and Europe to back companies as they scale globally.

Morningside is a Boston-based investment firm founded in 1986 as a family office for the Chan family. It makes venture capital investments in companies with novel science and technology, with deep expertise in life sciences, digital health, artificial intelligence, materials, and technology. The firm takes a long-term approach to building companies and emphasizes ethical conduct. In addition to its investment activities, Morningside supports charitable initiatives in education, research and healthcare, including collaborations with Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. The firm backs entrepreneurs with venture assistance, strategic guidance, and capital, focusing on bold, early-stage technology companies. It invests across sectors including AI, climate and sustainability, enterprise software, consumer technologies, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technologies. Based in Menlo Park, the firm manages several funds to support startups across stages, prioritizing ventures that address large markets and have potential for significant social and economic impact.

Antler is a global venture capital firm based in Singapore that backs early-stage technology companies. It runs incubation programs and provides a global community of co-founders, access to talent, expert advisors, expansion support, and capital to help startups grow. The firm targets a broad range of sectors, including healthcare, finance, software, energy, consumer and B2B technologies, and operates through regional programs across Europe, the United States, the United Kingdom, Southeast Asia, India, Africa, and beyond.

Versant Ventures is a healthcare-focused venture capital firm founded in 1999 and based in San Francisco, with offices in Canada, the United States and Europe. The firm invests across the healthcare sector at all stages, with an emphasis on discovery and development of novel therapeutics, and portfolios spanning biotechnology, pharmaceuticals, life sciences, healthcare devices and healthtech. Versant combines deep investment, operating and scientific expertise to support entrepreneurs through hands-on company building. It has backed more than 65 portfolio companies that have achieved acquisitions or IPOs.

Deerfield Management is a New York-based investment management firm founded in 1994 that focuses on healthcare. It engages in long-term structured investments in both public and private healthcare companies, and operates across investment activities, information services, and philanthropy. It acts as an investment adviser and supports private and public investments across life sciences, medical devices, diagnostics, digital health, and health services.

Polaris Partners is a Boston-based venture capital firm with offices in Boston and San Francisco that backs technology and life sciences companies across the United States and Europe. Founded in 1996, the firm partners with repeat entrepreneurs to support companies through multiple stages, from inception to growth, with a focus on software, healthcare information technology, digital health, life sciences, biotechnology, pharmaceuticals, genomics, and related sectors. Its investments span the business-to-business and business-to-consumer markets, software as a service, and other technology-enabled solutions, aiming to build durable platform companies and address significant needs in healthcare and technology.

High-Tech Gründerfonds is a Germany-based seed and early-stage venture capital firm focused on technology companies in Germany. Based in Bonn with an additional office in Berlin, it operates as a public-private partnership that supports high-tech startups across information technology, software, hardware, life sciences, chemistry and related fields. HTGF provides initial funding and follow-on capital to eligible young companies, often taking minority stakes and participating as lead or co-investor, while offering hands-on guidance from experienced investment managers and startup experts. Since its founding in 2005, the firm has backed numerous startups and facilitated the growth of portfolio companies through multiple funds aimed at early stages. The model combines both public support, involving government and financial institutions, with private investor participation to nurture startups from concept to market.

Right Side Capital Management is a San Francisco-based venture capital firm founded in 2010 that invests in early-stage technology startups. It specializes in pre-seed and seed rounds for capital-efficient companies, with a focus on the United States and Canada and occasional activity in Western Europe, Israel, Australia, and New Zealand. The firm typically makes 75 to 100 investments per year, with round sizes from 50,000 to 500,000 and pre-money valuations ranging from 1,000,000 to 3,500,000. Portfolio companies are typically located outside the San Francisco Bay Area and New York City, and the firm aims to provide a clear yes or no on opportunities within about two weeks.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

ARCH Venture Partners is a United States-based venture capital firm founded in 1986 and headquartered in Chicago, Illinois. The firm focuses on science-driven companies, with a track record of commercializing technologies developed at academic research institutions and national laboratories. It primarily invests in life sciences, biotechnology, pharmaceuticals, healthcare technology, and related sectors, and also backs software, materials, clean tech, and information technology across early to growth stages. ARCH emphasizes relationships with scientists and entrepreneurs, often taking early stakes and supporting subsequent rounds to help market entry and scale. The firm has raised multiple venture funds totaling several billion dollars and maintains a national and international reach with offices across North America.

F-Prime Capital is a venture capital investment firm based in Cambridge, Massachusetts. Founded in 1969 with roots in Fidelity Investments, it backs entrepreneurs across technology and life sciences, investing in sectors such as crypto, enterprise information technology, fintech, frontier technologies, health information technology and services, medtech and therapeutics, with a global reach across the Americas, Europe and Asia.

Venrock is a Palo Alto-based venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and early-stage technology and healthcare investments and has backed landmark companies such as Apple Computer, Intel, Illumina, Gilead Sciences, Athenahealth, DoubleClick, Nest, SlideShare, and Tudou. The firm manages multiple funds and maintains a US-focused investment approach, supporting entrepreneurs across information technology, life sciences, and related sectors throughout their growth journey.

Samsara BioCapital is a Palo Alto-based venture capital firm founded in 2016 that focuses on the healthcare sector, including biotechnology, pharmaceuticals, oncology, and life sciences. The firm seeks opportunities in the United States and provides investment advisory services as part of its activities, supporting companies developing innovative therapies and related technologies.

StartUp Health is a health innovation platform founded in 2011 that supports a global portfolio of health technology companies through a network of entrepreneurs known as Health Transformers. Its mission is to achieve health moonshots by advancing solutions across Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. The organization oversees more than 330 portfolio companies across six continents and 26 countries, working with leading health systems and investors to accelerate adoption and impact. By connecting entrepreneurs with health systems, researchers, and investors, StartUp Health aims to improve the health and wellbeing of people worldwide and transform healthcare delivery over a multi-decade timeframe.

Sofinnova Partners is an independent venture capital firm based in Paris, France, focusing on life sciences from seed to later-stage investments. It backs startups, early-stage companies, corporate spin-offs and occasionally turnaround situations in biopharmaceuticals/biotech, medical devices, and industrial biotechnology. The firm typically takes a lead or cornerstone role, often serving as the first institutional investor in Series A rounds, and actively supports portfolio companies through formation and beyond, including board participation. The firm manages more than €2 billion in life sciences assets.

Gaingels is a venture investment organization focused on LGBTQ+-founded and led companies and their allies, investing across stages from pre-seed to pre-IPO and maintaining a global portfolio. Founded in 2014 and based in New York, it operates as a syndicate with more than 130 portfolio companies and around $70 million deployed. The organization supports inclusive leadership by backing ventures that promote diverse C-suite and board representation and actively assists portfolio companies in recruiting diverse executive talent. It also fosters a global community of industry leaders, investors, operators, and entrepreneurs who pursue positive social change through business and successful investments.

Vivo Capital is a healthcare-focused investment firm founded in 1996 and headquartered in Palo Alto, California, with offices in Asia. The firm operates a multi-strategy platform including growth equity, private equity, venture capital, and public equity, and invests across biopharmaceuticals, specialty pharmaceuticals, medical devices, diagnostics, and healthcare services. It pursues opportunities globally, including the United States and China, and has invested in more than 290 companies. The team comprises physicians, scientists, entrepreneurs, operating executives, and industry experts, and the firm manages about $5.8 billion in assets.

Redmile Group is a San Francisco-based private equity firm with an office in New York that focuses on investments in the healthcare sector, pursuing opportunities across venture, growth, and crossover stages to support healthcare companies with strategic capital and partnerships.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization founded in 1982 that supports the region's technology ecosystem. Based in Philadelphia, it acts as a capital provider and catalyst for early-stage and growing technology companies across information technology, health, and physical sciences by offering seed-stage funding and related resources to accelerate commercialization. The organization facilitates university–industry partnerships and regional initiatives that connect scientific research with market opportunities, with the aim of creating jobs and strengthening entrepreneurial communities in Southeastern Pennsylvania. Through its programs and partnerships, it supports adoption of new technologies and helps build a robust regional innovation ecosystem.

Andreessen Horowitz is a venture capital firm based in Menlo Park, California. Founded in 2009 by Marc Andreessen and Ben Horowitz, it funds software and technology companies across seed to growth stages, with emphasis on web and mobile applications, cloud infrastructure, enterprise software, fintech, consumer Internet, artificial intelligence, and biotech-adjacent ventures. The firm focuses on technology-enabled businesses and provides strategic support and networks to portfolio companies.

Pfizer is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines across a broad range of therapeutic areas. It maintains an extensive portfolio of prescription drugs and vaccines, with notable products such as Prevnar 13, Ibrance, and Eliquis. The company serves customers worldwide, with substantial international and emerging-market sales. Through ongoing research and development, Pfizer pursues new treatments to address major diseases, including cancer and neurodegenerative conditions, and aims to improve patient outcomes by delivering safe, effective, and accessible therapies. Founded in 1849 and headquartered in the United States, Pfizer operates globally to advance health care through science, partnerships, and scalable manufacturing capabilities.

Mission BioCapital is a life science venture capital firm that backs early‑stage biotechnology companies. Based in Cambridge, Massachusetts, the firm draws on a leadership team with a long history of investing in and launching numerous early‑stage life science ventures. It operates in regions with strong research, discovery, and venture capital ecosystems and is known for providing deep expertise and active support to its portfolio companies.

Kurma Partners is a Paris-based investment management company focused on funding innovation in healthcare and biotechnology across Europe. Established in 2009, it targets early-stage to development capital for life sciences companies and digital health ventures, spanning healthcare, biotechnology, and related technology sectors. The firm pursues a hands-on approach to support research-driven startups, leveraging connections with research institutes and hospitals to advance therapeutic and medical innovations. Through its activity as a private equity and venture investor, Kurma Partners seeks to back companies throughout their growth trajectory, from initial concept to market readiness, helping them navigate clinical development, regulatory pathways, and commercialization in the European market.

SV Health Investors is a United States‑headquartered healthcare and life sciences venture capital and growth equity firm. Formerly known as SV Life Sciences, it supports entrepreneurs who create breakthrough companies and treatments across biotech, medical devices, and healthcare services. With offices in Boston, San Francisco and London, the firm has over two billion dollars of capital under management across seven private healthcare funds and more than two decades of activity in the US and Europe.

Casdin Capital is a New York-based investment firm focused on life sciences and healthcare. Founded in 2012 by Eli Casdin, the firm pursues private investments and research-driven opportunities across early- to late-stage companies in these sectors and is described as a venture capital firm and a registered investment adviser.

Forbion is a Netherlands-based venture capital firm focusing on life sciences and bioeconomy companies across Europe and North America. It invests in a broad spectrum of sectors including pharmaceuticals, biotechnology, MedTech, autoimmune and inflammatory diseases, cardiovascular and metabolic disorders, CNS conditions, oncology, ophthalmology, orphan and rare diseases, and related environmental, food, and materials technologies. The firm pursues both early-stage and growth investments in life sciences and technology companies, providing capital and strategic support to advance drug development, medical devices, and other innovations in health and bioscience.

HBM Healthcare Investments is a Switzerland-based investment firm founded in 2001 and based in Zug. It concentrates on the healthcare sector, spanning human medicine, biotechnology, medical technology and diagnostics. The firm maintains a diversified portfolio that includes private companies, public companies, funds, cash and other assets, reflecting exposure across different stages and sectors within healthcare.

Lightspeed Venture Partners is a global venture capital firm based in Menlo Park, California, with additional offices in Beijing, Shanghai, New Delhi, and Israel. The firm backs early and growth stage start-ups across sectors such as enterprise software, consumer technology, fintech, healthtech, cleantech, and information technology, and pursues opportunities in the United States, Asia, and Israel. It funds a broad range of rounds, including seed, early, later, and expansion, and also provides debt financing for start-ups and growth companies. Lightspeed focuses on helping entrepreneurs scale through capital, strategic guidance, and operational support, and maintains a diversified portfolio across enterprise, consumer, big data, mobile, and internet-enabled sectors.

FJ Labs is a New York-based venture capital firm founded in 2015 by Fabrice Grinda. It is stage-agnostic and focuses on marketplaces and consumer-facing startups, making seed and Series A investments. Typical checks range from 50,000 to 5,000,000 dollars. The firm supports early-stage companies across sectors such as e-commerce, fintech, ad tech, mobile, and software-as-a-service, seeking opportunities with high growth potential in the United States and internationally. Its portfolio includes a mix of consumer brands and marketplace platforms, reflecting an emphasis on business models that connect buyers and sellers or enable direct consumer experiences. FJ Labs aims to back entrepreneurs building scalable, disruptively positioned products and services, often partnering with founders early in their development to help accelerate growth.

Keiretsu Forum is an international investment community of accredited private equity investors, venture capitalists and corporate/institutional investors. Founded in San Francisco in 2000, it operates as a worldwide network that structures access to high-quality deal flow and investment opportunities through regional chapters across the United States, Europe and Asia. It is described as the world’s largest invitation-only angel investor network, with thousands of investor members who participate in funding opportunities for early- to growth-stage companies in technology, healthcare, energy, consumer products and other sectors. The forum emphasizes collaboration among members and partner resources to support due diligence, syndication and capital deployment, enabling private capital to back high-potential ventures.

IP Group is a London-based venture capital firm that focuses on commercialising intellectual property from research-intensive institutions. It creates value by identifying early-stage IP, developing it into commercially viable opportunities, and forming strategic partnerships to support portfolio companies. The firm provides capital, strategic guidance, and industry insight to science- and technology-based businesses, with emphasis on clean technology, life sciences, and deep tech. With more than twenty years of experience, IP Group supports the growth of science and technology companies from inception toward scale, helping translate research into market-ready products and accelerate their impact.

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011, that manages investment portfolios and provides asset management services to clients across sectors, with a focus on software as a service companies, and analyzes market trends to inform its investment decisions while operating in finance, technology, and real estate.

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across stages. The firm focuses on transformational technologies and has supported early backers of SpaceX, Palantir, Facebook, and Airbnb. It pursues a founder-friendly approach that provides significant support with minimal interference, and it invests globally across sectors including software, artificial intelligence, aerospace, energy, healthcare, cybersecurity, biotech, and information technology. The firm targets opportunities from seed to growth stages and emphasizes solving difficult problems through innovative technology.

Samsung Electronics is a global technology company based in South Korea that designs, manufactures, and sells a wide range of electronics and device solutions. Its portfolio spans consumer electronics (mobile devices, televisions, home appliances, cameras), information technology products (PCs, peripherals, printers), semiconductors, memory and storage, and display technologies. The company also provides telecommunications infrastructure and related services, and conducts extensive research and development to advance core technologies. With a global footprint across Korea, China, the Americas, Europe, and the Asia Pacific, Samsung Electronics is a leading supplier of smartphones, memory chips, and displays, and it coordinates significant manufacturing and supply chain activities to support its varied product lines.

European Investment Fund (EIF) is a public institution established in 1994 to improve access to finance for Europe's small and medium-sized businesses. It designs and develops venture capital and guarantee instruments to support SMEs and to catalyse private investment, aiming to build a robust European equity ecosystem. EIF engages in venture capital, growth capital, and guarantee operations, backing innovative entrepreneurs primarily in technology and life sciences, as well as across other sectors. Through cornerstone investments and fund participation, EIF seeks to crowd in private investors and stimulate venture activity across Europe. Its equity portfolio has grown substantially, with assets under management exceeding EUR 14 billion, reflecting its broad role in strengthening SME finance and supporting entrepreneurship and growth.

Atlas Venture is a Cambridge, Massachusetts–based venture capital firm founded in 1980 that specializes in life sciences and technology. It pursues seed-led venture creation and early-stage investments to build scalable companies in biopharmaceuticals, diagnostics, medical devices, and related biomedical technologies, as well as software and other technology sectors. The firm often leads investments and seeks board representation to support portfolio companies as they grow toward acquisition or public offerings. Atlas operates with dedicated life sciences and technology teams and maintains an international footprint across the United States and Europe.

Lux Capital is a venture capital firm based in New York City and Silicon Valley that funds seed- and early-stage technology and science startups. It concentrates on deep tech across the physical and life sciences, investing in biochemistry, material science, electronics, infrastructure, aerospace, satellites, drones, and space technologies, as well as software, machine learning, and artificial intelligence, genomics and synthetic biology. The firm takes an active role in helping entrepreneurs build high-growth companies and has a track record of launching more than 20 portfolio companies. With a technically engaged approach, Lux supports portfolio progress by leveraging deep domain insight and industry connections to drive leadership and scale.

Sequoia Capital is a venture capital firm founded in 1972 and based in Menlo Park, California. It pursues investments across multiple sectors, including information technology, healthcare, manufacturing, mobile, nanotechnology, financial services, internet, energy, media, and retail, and provides early to growth-stage funding coupled with strategic support to help founders build lasting, category-defining companies.

Legend Capital is a Beijing-based venture capital firm and the investment arm of Legend Holdings, established in 2001 to become a leading venture capital manager in China. It manages up to about US$700 million across four funds and focuses on high-growth ventures with operations in China or markets related to China, particularly in early-stage information technology including network applications and services, outsourcing and professional services, and infrastructure components such as IC design, as well as mid-market growth in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. As an active investor, Legend Capital provides portfolio companies with strategic resources, business development support, and market guidance to help them scale in the Chinese market. Notable investments include Joyo.com, SinoCom, Solarfun Power, Spreadtrum Communications, China Sunshine Paper, and VanceInfo, among others.

Korea Investment Partners is a Seoul-based venture capital and private equity firm with decades of experience in funding bold, innovative entrepreneurs. It operates globally with offices in Shanghai, Beijing, and Sunnyvale and manages multiple funds totaling several billions of dollars in assets under management. As the venture capital and private equity arm of Korea Investment Holdings, KIP backs a broad range of sectors including information technology, healthcare, life sciences, manufacturing, mobility and gaming, as it seeks to help companies scale and commercialize new technologies. The firm emphasizes long-term value creation and has built a diversified portfolio across Asia and beyond.